Orit Itzhaki
Tel Litwinsky, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Anti-CD19 CAR T-cell therapy as salvage treatment for refractory cutaneous polyarteritis nodosa.
Journal: Annals of the rheumatic diseases
Published: May 23, 2026
Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous haematopoietic stem cell transplantation: a case series.
Journal: Rheumatology (Oxford, England)
Published: November 24, 2025
CAR-T as a salvage treatment in polyrefractory RA.
Journal: Rheumatology (Oxford, England)
Published: November 04, 2025
Engineered mRNA backbones for gene expression in human T cells.
Journal: Molecular therapy. Nucleic acids
Published: August 15, 2025
Distinct Cellular and Molecular Patterns in Pretreatment Peripheral Blood Are Associated with CAR T-cell Outcomes in Diffuse Large B-cell Lymphoma.
Journal: Cancer research
Published: August 12, 2025
Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma: a multicenter propensity scorematched analysis.
Journal: Haematologica
Published: June 11, 2025
T-ICAHT: grading and prognostic impact of thrombocytopenia after CAR T-cell therapy.
Journal: Blood
Published: February 19, 2025
CD28-costimulated CD19 CAR-T cells for pediatric mature non-Hodgkin B-cell lymphoma.
Journal: Bone marrow transplantation
Published: February 06, 2025
HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion.
Journal: Cell
Published: January 08, 2025
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: July 19, 2024
Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression.
Journal: Current research in translational medicine
Published: May 09, 2024
Last Updated: 09/26/2026